跳至主要内容
临床试验/IRCT2015062017994N1
IRCT2015062017994N1已完成3 期

Safety and efficacy of Linola F® Cream (Dr. August Wolf Co) on mild to moderate forms of atopic dermatitis

Sina Tejart Pishgam® company0 个研究点目标入组 25 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 years 至 no limit(—)
性别
All

入选标准

  • Inclusion Criteria:
  • Case of Mild to moderate atopic dermatitis
  • Aged (>2) years old
  • At least 2 lesions on arms or legs with identical local SCORAD
  • Written Informed Consent
  • Having a negative pregnancy test
  • Willingness to actively participate in the study and to come to the scheduled visits respectively willingness of parents/legal guardians to actively participate in the study and to come to the scheduled visits
  • Willingness to discontinue the use of any conventional skin care products (e.g. creams, lotions, sunscreens) at the treatment areas of Linola F throughout the course of the study

排除标准

  • Pregnancy or lactation
  • Severe Atopic eczema (local SCORAD >12)
  • Drug addicts, alcoholics
  • One of the following serious illnesses, if not medicated: cardiovascular diseases, asthma, hypertension
  • Active skin disease at test area (except atopic dermatitis)
  • Moles, tattoos, scars, hairs, dark pigmentation etc. at the test area that could influence the investigation
  • Documented allergies to cosmetic products
  • History of HIV
  • History of Hepatitis C
  • History of Hepatitis B
  • Being involved in any other research project /clinical trial

研究者

发起方
Sina Tejart Pishgam® company

相似试验

inola F® on Skin Physiology of patients with atopic... | 临床试验